Harvard Study Shows Radiation Therapy Needed with Lumpectomy to Effectively Treat Breast Cancer

Publication
Article
OncologyONCOLOGY Vol 10 No 4
Volume 10
Issue 4

Breast-conserving surgery without radiation therapy is not an effective treatment for early-stage breast cancer, a Harvard Medical School study concludes.

Breast-conserving surgery without radiation therapy is not aneffective treatment for early-stage breast cancer, a Harvard MedicalSchool study concludes.

The study results were presented at the annual meeting of theAmerican Society for Therapeutic Radiology and Oncology (ASTRO)in Miami Beach, Florida, by Dr. James Hayman of the Joint Centerfor Radiation Therapy, Harvard Medical School.

According to Dr. Hayman, the study team was surprised that a substantialnumber of patients who were not given radiation therapy had cancerrecur in their breasts. These patients, he explained, were verycarefully chosen because all indications were that they woulddo well with lumpectomy alone.

The 3-year rate of repeat cancer in the breast in this group wasmore than 10%, according to Dr. Hayman.

In 76% of the patients, breast cancer was first detected by mammography-anindication that the cancer was small and could not even be felt.Nevertheless, lumpectomy alone did not prove to be as effectiveas conservative surgery combined with radiation therapy has been,he added.

Overall, of a total of 87 patients who had lumpectomy but no radiationtherapy, 14 have had a recurrence of breast cancer, Dr. Haymansaid. This recurrence rate of 16% represents "a substantialrisk of local recurrence following treatment with lumpectomy alone,"he added.

"At this time, we are not able to identify any group of patientswith early breast cancer who are candidates for conservative surgerywithout radiation therapy," Dr. Hayman said. "Surgeryalone for early-stage breast cancer does not appear to be an acceptabletreatment."

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.